Canada Life
PHAT icon

Canada Life’s Phathom Pharmaceuticals PHAT Stock Holding History

Canada Life’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76K Hold
6,818
– – ﹤0.01% 1715
2025
Q4 		$113K Buy
+6,818
New +$97.4K ﹤0.01% 1704
2025
Q2 		– Sell
-2,839
Closed -$18K – 1985
2025
Q1 		$18K Hold
2,839
– – ﹤0.01% 1951
2024
Q4 		$23K Hold
2,839
– – ﹤0.01% 1950
2024
Q3 		$51K Hold
2,839
– – ﹤0.01% 1945
2024
Q2 		$29K Hold
2,839
– – ﹤0.01% 2005
2024
Q1 		$30K Hold
2,839
– – ﹤0.01% 2055
2023
Q4 		$26K Hold
2,839
– – ﹤0.01% 2081
2023
Q3 		$29K Buy
2,839
+1,989
+234% +$27.3K ﹤0.01% 2095
2023
Q2 		$12K Hold
850
– – ﹤0.01% 2229
2023
Q1 		$6K Hold
850
– – ﹤0.01% 2307
2022
Q4 		$10K Hold
850
– – ﹤0.01% 2324
2022
Q3 		$9K Hold
850
– – ﹤0.01% 2353
2022
Q2 		$7K Hold
850
– – ﹤0.01% 2400
2022
Q1 		$12K Hold
850
– – ﹤0.01% 2416
2021
Q4 		$17K Hold
850
– – ﹤0.01% 2407
2021
Q3 		$27K Hold
850
– – ﹤0.01% 2381
2021
Q2 		$29K Buy
850
+707
+494% +$25.3K ﹤0.01% 2411
2021
Q1 		$5K Sell
143
-728
-84% -$30.5K ﹤0.01% 2578
2020
Q4 		$29K Hold
871
– – ﹤0.01% 2466
2020
Q3 		$32K Hold
871
– – ﹤0.01% 2308
2020
Q2 		$28K Buy
+871
New +$33.5K ﹤0.01% 2420

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Canada Life's PHAT Position: Q1 2026 in Review

Canada Life held its Phathom Pharmaceuticals (PHAT) position steady in Q1 2026 at 6,818 shares worth $76K. The position accounts for ﹤0.01% of the portfolio, ranked #1715.

Canada Life first reported a position in PHAT in Q2 2020 and has held it in 22 quarters since. The position peaked at $113K in Q4 2025. 174 funds tracked by Wall St. Rank hold PHAT as of Q1 2026.

  • Canada Life held 6,818 shares of Phathom Pharmaceuticals worth $76K as of Q1 2026.
  • Canada Life left its Phathom Pharmaceuticals share count unchanged in Q1 2026.
  • Phathom Pharmaceuticals made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1715 holding.
  • Canada Life first reported a position in Phathom Pharmaceuticals in Q2 2020 and has held it in 22 quarters since.
  • Canada Life's Phathom Pharmaceuticals position peaked at $113K in Q4 2025.
  • 174 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.